Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Molly M. Morgan"'
Autor:
Brian P. Johnson, Ross A. Vitek, Molly M. Morgan, Dustin M. Fink, Tyler G. Beames, Peter G. Geiger, David J. Beebe, Robert J. Lipinski
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Paracrine signaling in the tissue microenvironment is a central mediator of morphogenesis, and modeling this dynamic intercellular activity in vitro is critical to understanding normal and abnormal development. For example, Sonic Hedgehog (Shh) signa
Externí odkaz:
https://doaj.org/article/d8b3b36fea6a41af81b6b68e4013d24d
Autor:
Molly M. Morgan, Megan K. Livingston, Jay W. Warrick, Eli M. Stanek, Elaine T. Alarid, David J. Beebe, Brian P. Johnson
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Abstract The estrogen receptor (ER) regulates the survival and growth of breast cancer cells, but it is less clear how components of the tissue microenvironment affect ER-mediated responses. We set out to test how human mammary fibroblasts (HMFs) mod
Externí odkaz:
https://doaj.org/article/93d31729cd3141899c8dc7350744dfce
Autor:
Sheena C. Kerr, Brian P. Johnson, Megan K. Livingston, Molly M. Morgan, Karina M. Lugo-Cintrón, Amani A. Gillette, Melissa C. Skala, Joshua M. Lang, Logan Florek, David J. Beebe, Peter F. Favreau
Publikováno v:
Integrative Biology
The prostate tumor microenvironment (TME) is strongly immunosuppressive; it is largely driven by alteration in cell phenotypes (i.e. tumor-associated macrophages and exhausted cytotoxic T cells) that result in pro-tumorigenic conditions and tumor gro
Autor:
Elaine T. Alarid, Brian P. Johnson, Linda A. Schuler, David J. Beebe, Molly M. Morgan, Jordan C. Ciciliano
Publikováno v:
Integr Biol (Camb)
Accumulating evidence suggests that our ability to predict chemical effects on breast cancer is limited by a lack of physiologically relevant in vitro models; the typical in vitro breast cancer model consists of the cancer cell and excludes the mamma
Publikováno v:
The FASEB Journal. 33:8623-8633
Aromatase inhibitors are the preferred treatment for certain women with estrogen receptor (ER)-positive breast cancer, but evidence suggests that women with obesity experience aromatase inhibitor resistance at higher rates. To compare how stromal cel
Autor:
Brian P. Johnson, Ross A. Vitek, Molly M. Morgan, Dustin M. Fink, Tyler G. Beames, Peter G. Geiger, David J. Beebe, Robert J. Lipinski
Publikováno v:
Frontiers in Cell and Developmental Biology
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Frontiers in Cell and Developmental Biology, Vol 9 (2021)
Paracrine signaling in the tissue microenvironment is a central mediator of morphogenesis, and modeling this dynamic intercellular activityin vitrois critical to understanding normal and abnormal development. For example, Sonic Hedgehog (Shh) signali
Autor:
William T. Daly, William L. Murphy, María Virumbrales-Muñoz, Megan K. Livingston, Brian P. Johnson, Molly M. Morgan, David J. Beebe
Publikováno v:
ACS biomaterials scienceengineering. 5(11)
Extracellular matrix (ECM) mimicking hydrogel scaffolds have greatly improved the physiological relevance of in vitro assays, but introduce another dimension that creates variability in cell related readouts when compared to traditional 2D cells-on-p
Autor:
Ismael Gomez, David J. Beebe, Jose M. Ayuso, Kari B. Wisinski, Suehelay Acevedo-Acevedo, Molly M. Morgan, Tiffany M. Heaster, Melissa C. Skala, Sean P. Palecek, Karina M. Lugo-Cintrón, Amani A. Gillette
Publikováno v:
EBioMedicine
Background Ductal carcinoma in situ (DCIS) is the earliest stage of breast cancer. During DCIS, tumor cells remain inside the mammary duct, growing under a microenvironment characterized by hypoxia, nutrient starvation, and waste product accumulation
Autor:
Ana M. Reyes-Ramos, Karla P Ramos-Cruz, Molly M. Morgan, Yatao Shi, Maribella Domenech, Yasmín R. Álvarez-García, Loren E. Stallcop, David J. Beebe, Jay W. Warrick, Lingjun Li
Publikováno v:
Lab on a Chip. 18:451-462
Tape-based razor-printing is a flexible and affordable ultra-rapid prototyping approach for microscale device fabrication. However, integration of this prototyping approach into cell-based assay development has been limited to proof of principle demo
Autor:
Joshua M. Lang, David J. Beebe, Jaime M. Sperger, Zachery D. Schultz, Charlotte N. Stahlfeld, Molly M. Morgan, Anupama Singh, Rory M. Bade, Jennifer L. Schehr, Madalyn S. Gill, Jay W. Warrick, Hannah M. Pezzi
Publikováno v:
Clinical Cancer Research. 26:B40-B40
The efficacy of androgen receptor (AR) signaling inhibitors (ARSIs) in prostate cancer is limited by both de novo and acquired resistance. Two well-described mechanisms of resistance to ARSIs are the development of constitutively activated AR splice